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Background and Purpose: Heart failure (HF) is an increasingly prevalent disease and a major 
cause of morbidity and mortality around the world. Depression is more common in people with 
HF than in the general population however, it is under-diagnosed and under-treated. The purpose 
of this project was to implement a depression assessment program to improve staff knowledge 
about evidence-based depression screening and management guidelines, as well as increase the 
number of patients screened for depression in an outpatient cardiology setting. 
Method and Results: Providers and staff participated in an educational presentation that covered 
various topics including depression incidence in HF patients, evaluating depression in the primary 
care setting, interpretation of the PHQ-9 score, and depression screening guidelines & 
recommendations. A pre- and post-test was used to measure if there was an improvement in staff 
knowledge after the educational intervention. The total staff knowledge rating of the pre-test 
showed a mean score of 5.9 and post-test score of 8.1. Changes from pre-test to post-test were 
assessed using a paired samples t-test which showed the results to be significant: t(9) = -2.39, 
p<.01. The t-value was then converted to a correlation to assess strength of effect. Results 
indicated a large effect size (i.e., >.50) with an r = .62. During the PHQ-9 pilot period, the 
depression assessment was administered to HF patients. The patient’s PHQ-9 score was shared 
with the cardiologist for further evaluation and management. The number of completed PHQ-9 
surveys were tracked at weekly intervals. Of the 87 patients who completed the PHQ-9 survey, 
the average score was 2.94. 61.7% of patients scored 0 to 4 (no depression), 9.3% scored 5 to 9 
(mild depression), 9.3% scored between 10 to 14 (moderate depression), less than 1% scored 
between 15 to 19 (moderate-severe depression), and 0% of patients scored greater than 20 (severe 
depression). 2 patients were referred to the psychologist for further evaluation.  
 v 
Discussion: Depression is under-recognized and under-treated in the HF population due to a lack 
of systematic assessment. Administering depression screenings in a cardiology outpatient setting 
affords a rich opportunity for identifying and managing patients at risk for psychosocial issues. 
Although our findings suggest a low prevalence of depression in the HF population, this project 
supports the continued use of the PHQ-9 survey as a cost-saving measure to enhance patient care. 
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CHAPTER 1: INTRODUCTION 
 
Background/Problem 
Heart failure (HF) is a major cause of morbidity and mortality around the world. Among 
cardiovascular diseases, HF remains the third leading cause of death in the United States 
(American Heart Association, 2018). This condition afflicts more than 61.7 million people 
worldwide and 5.7 million adults nationally (Ponikowski et al., 2014). HF is one of the most 
expensive and difficult conditions to manage due to its chronic nature and worsening 
progression.  
There are several modifiable risk factors that have been linked to adverse outcomes in the 
HF population. Depression has been proven to be an independent modifiable risk factor that is 
commonly experienced in people with HF (Moudgil & Haddad, 2013). The co-prevalence of HF 
and depression has been associated with an increased risk for recurrent cardiovascular events and 
mortality, as well as higher healthcare costs and lower quality of life. Clinically significant 
depression has been reported in approximately 20% of patients (Rutledge et al., 2006). The 
prevalence of patients with HF and depression vary from 11% to 35% in the outpatient setting 
and 35% to 70% in the inpatient population (Rutledge et al., 2006).  
Multiple professional societies such as the American Heart Association (AHA) and 
American College of Cardiology (ACC) have recommended systematic depression screenings in 
HF patients however, depression remains under-diagnosed and under-treated. Screening for 
depression has yet to become a regular practice during routine visits. Proper identification and 
management of depression may be a practical and low-cost intervention to improve health 





Facilitating change within a large organization required a systems-based approach. The 
Iowa Model of Evidence-Based Practice (see Figure 1) utilizes an algorithmic flow chart to 
evaluate current nursing practices and identify areas of improvement (Titler et al., 2001). There 
are seven steps of the Iowa Model: Selection of a topic; Forming a team; Evidence retrieval; 
Grading the evidence; Developing an evidence-based project (EBP) standard; Implementing the 
EBP; Evaluation.  
 
Figure 1. The Iowa Model for Evidence-Based Practice 
Note: Retrieved from Titler et al. (2001) 
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Identifying triggers. The Iowa Model recommends identifying problem-focused or 
knowledge-focused triggers to stimulate critical thinking and guide the development of possible 
EBP changes (Titler et al., 2001). Since 2008, the deaths attributable to HF have been increasing 
in Honolulu (see Figure 2). The Pali Momi Heart Center (PMMC) services a large population of 
HF patients in Central Oahu. In 2011, HF was the leading cause of preventable hospitalization in 
Leeward Oahu (Health Communities Institute, 2013). Mental health was the most frequent cause 
for hospitalization among the 15 different preventable hospitalizations as it was the top reason 
for 1,176 hospitalizations in West Oahu (see Table 1). This was the trigger for this EBP project. 
The increasing mortality rates and hospitalizations attributable to HF and mental health issues in 
Hawaii need to be addressed. More research is needed on interventions that will improve health 




Figure 2: Congestive Heart Failure Death Rate – Change over time in Honolulu County 





Table 1: Hospitalization Rates due to Preventable Causes in West Oahu, 2011 
 
 
Note: Retrieved from Hawaii Pacific Health Community Needs Assessment (2013). 
 
Organizational priority. PMMC strives to improve outpatient care and decrease 
mortality rates through their “Quality of Care” initiatives. The 2012-2013 PMMC Community 
Health Needs Assessment report was created to provide a meaningful understanding of the health 
needs in the community. The report identified health disparities, the needs of vulnerable 
populations, and unmet health needs or gaps in services. Special consideration for mental health, 
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a chronic condition that significantly influences overall health, was deemed critical for achieving 
population health goals. Despite the recommendations made by the American Heart Association 
(AHA), systematic depression screenings in patients with chronic heart disease have not been 
implemented in routine visits, yet. As there is no protocol in place, proper treatment and quality 
care for HF patients poses a barrier to management of mental health concerns in the HF 
population.  
Team formation. The implementation of this project was supported by the facility’s 
outpatient director, office manager, and quality improvement (QI) team. The QI team included 
the Heart Center’s cardiologists, registered nurse, medical assistants and front desk secretaries.  
Literature Review and Synthesis 
An electronic search was completed utilizing PubMed, CINAHL, Google Scholar, and 
the National Guideline Clearinghouse. Primary keywords and medical subject heading terms 
included: “depression”, “heart failure”, “depression screening tools”, “depression screening 
tools/instruments”, “depression assessment”, and “depression measurement in heart failure”.  
Articles were limited to publication within the last 20 years, English language, adult, 
human subject results, and outpatients. Additional sources were identified using article reference 
lists.  
A total of 55 articles published between 1998 and 2017 were identified; 35 were omitted 
based on lack of relevance to this project. The remaining 20 articles were examined. In addition, 
the following guidelines and recommendations for Depression Screening were reviewed: 
American Heart Association (AHA), U.S. Preventive Services Task Force (USPSTF), and 
American Academy of Family Physicians (AAFP). To grade evidence, Mosby’s Levels of 
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Evidence Pyramid (see Figure 3) was used. Clinical practice guidelines (CPGs), review of CPGs, 
and literature reviews were classified on Mosby’s “Other” level of literature. 
 
Figure 3. Mosby’s Level of Evidence. 
Note. Retrieved from Melnyk & Fineout-Overhold (2005). 
 
Depression in heart failure patients. Depression was a common comorbidity in patients 
with HF (Glassman, 2018). Results from Rutledge et al.’s meta-analysis indicated that 
depression was present in 10 to 40% of HF patients, with greater prevalence rates in patients 
with a higher New York Heart Failure (NYHA) classification (2006) (see Table 2). 
Epidemiologists have recognized depression as an independent risk factor for coronary artery 
disease, equal to smoking, arterial hypertension and hyperlipidemia (Moudgil & Haddad, 2013). 
The combination of HF and depression has been associated with poorer clinical outcomes, 
decreased adherence to medical treatment, diminished quality of life and functionality, higher 
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hospital readmission rates, and a higher risk of mortality compared to HF patients without 
depressive symptoms (Rustad, Stern, Hebert, & Musselman, 2013). 




Note. Retrieved from Rutledge et al. (2006). 
 
Depression screening tools. In 2008, the AHA Science Advisory published an article 
that recommended screening for depression with either of two brief screening tools for 
depression (i.e., the 2-item or 9-item Patient Health Questionnaire [PHQ]) (Lichtman et al., 
2008). Hammash et al. (2012) found that the PHQ-9 was a consistent and reliable depression 
screening instrument and supported its consistency when compared to the Beck’s Depression 
Inventory (BDI) as the gold-standard. McManus, Pipkin, and Whooley (2005) found that the 
PHQ-9 was efficient and easily administered. It could be used successfully on inpatient cardiac 
units with good acceptance by staff and patients. PHQ-9 cut-off of ≥ 10 have resulted in 
excellent specificity (90%) but poor sensitivity (54%) in patients (McManus, Pipkin & Whooley, 
2005). Smolderen et al. (2011) and Lee et al. (2017) found that using the PHQ-9 alone, compared 
to using the PHQ-2 and PHQ-9, was more effective in detecting rates of depression and 
treatment. After evaluating the AHA’s recommendation of using the 2-step protocol of the PHQ 
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when screening for depression, it was found that the 2-step method has no clear advantage 
compared with the PHQ-2 alone or the PHQ-9 alone for predicting mortality in HF patients with 
depressive symptoms.  
Conversely, McGuire, Eastwood, Macabasco-O’Connell, Hays, and Doering (2013) 
found that the PHQ-2 is as sensitive and specific as the longer versions when administered by 
staff nurses at an urban cardiac care unit. When comparing the three version of the PHQ 
screening instrument, each version had excellent specificity statistics of 91.2%, 92.6%, and 
93.4%, respectively. For older persons, the sensitivity of the PHQ-2 has been reported as high as 
100%.  
Several studies highlighted the challenge of screening for depression in HF patients due 
to the overlap of symptoms. Fatigue, weight loss, poor sleep, and inability to concentrate were 
several symptoms attributed by both conditions (Rustad et al., 2013). Delville and McDougall 
(2008) also suggested that several instruments did not account for symptom overlapping and 
should be avoided when working with the HF population. Screening instruments that should not 
be used using this criterion include the Beck Depression Inventory (BDI), the Geriatric 
Depression Scale (GDS), the Center for Epidemiologic Studies-Depression Index (CES-D), the 
Hospital Anxiety and Depression Index, the Medical Outcome Survey-Depression Instrument, 
and the Zung depression Scale.  
Depression treatment and management. There were several psychopharmacologic 
treatments indicated for depressed HF patients. Selective serotonin reuptake inhibitors (SSRIs) 
seemed to have significant beneficial effect with nearly no adverse cardiovascular effects. Roose 
et al. (1998) conducted a small, open-treatment, nonrandomized study where SSRI fluoxetine 
was given to 27 depressed psychiatric inpatients with CHF. Decreased heart rates were reported 
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by 6%, but no adverse effects such as tachycardia, hypotension, angina pectoris, extra systoles, 
or myocardial infarction occurred. In a different study by Glassman et al. (2002), SSRI sertraline 
was given to a group of 186 patients with CHF and severe depression. In this 6-month, double-
blind, randomized study, medicated patients saw a significant improvement in depression scores 
(mean change of -12.3) when compared to the placebo group (-8.9).  
Moudgil and Haddad (2013) suggested cognitive behavioral therapy (CBT) as a treatment 
for depression that is holistic and effective in decreasing depressive symptoms, increasing sleep 
efficiency, and ensuring completion of treatment. CBT was found to be even more effective than 
medication therapy alone. The strongest evidence for CBT involved a two-year follow-up study 
that concluded that patients who received a combination of medication (i.e. monoamine oxidase 
inhibitor) and cognitive therapy were more likely to relapse, compared to patients who received 
cognitive therapy alone (Moudgil & Haddad, 2013). 
Innovation/Objectives 
PICO statement. To clarify the aims and objectives of this project, the following 
problem, intervention, comparison, and outcome (PICO) statement and clinical question were 
developed. 
Problem/Population (P): Depression incidence in adult heart failure patients. 
Intervention (I): Implement a depression assessment program that involves educating 
staff on evidence-based depression assessment and management guidelines. 
 Comparison (C): Current practice or no screening.  
Outcome (O): Improve staff knowledge about depression screening and management 




Clinical Question. Will the implementation of a depression assessment program improve 
staff knowledge about evidence-based depression screening and management protocols, as well 
as increase the number of patients screened for depression at the Pali Momi Heart Center Heart 
Center? 
 
CHAPTER 2: METHODS 
Project Design (QI/EBP) 
The purpose of this EBP project was to translate the research on depression screening and 
management in the HF population. By applying recommended practices in real clinical settings, 
organizations could recognize areas of improvement and make system-level changes to continue 
delivering high-quality health care.  
The main advantage of utilizing the EBP approach was the applicability of project 
interventions in other outpatient practice settings within the medical care system. Also, the user-
friendly algorithmic guide of the Iowa Model of Evidence-Based Practice helped implement 
research into clinical practice (Titler et al., 2001). 
Human Patients Consideration 
An Institutional Review Board (IRB) was not necessary for this quality improvement 
project. An IRB is needed for projects that meet the definition of research however, this project 
did not control trials and patients were not randomized to different treatments. Patients were not 
mandated to participate or provide information if they did not want to. This project was not 
designed to cause any additional harm than any other usual treatment. Patients may have 
benefitted from receiving a more comprehensive depression assessments and physicians may 
benefit from receiving a better clinical picture of the patient’s mental health.  All patient 
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information was strictly confidential, and participants’ rights were protected throughout the 
implementation of this project.   
Practice Change Description 
Increase staff knowledge. An educational presentation was conducted by the DNP 
candidate during the medical staff’s lunch hour at the Heart Center. Food and drinks were 
provided by the leadership team for the staff’s participation. A pre- and post-test prior to and 
following the presentation was administered to identify if there was an improvement in staff 
knowledge (Appendix A).  
During the 30-minute PowerPoint presentation, providers and staff were educated on 
various topics including depression incidence in HF patients, evaluating depression in the 
primary care setting, interpretation of the PHQ-9 score, and depression screening guidelines & 
recommendations by the AHA. Additionally, discussion of how PHQ-9 results were to be 
communicated between medical assistant and provider, understanding PHQ-9 scores, and 
appropriate interventions and follow-up were facilitated during this meeting. A summary of the 
educational presentation content is below: 
1. Overview of depression and heart failure 
2. Consequences of undiagnosed and untreated depression in HF patients 
3. Barriers to mental health care 
4. Screening HF patients for depression 
a. Why should we screen for depression? 
b. When and how often should patients be screened? 
c. What is the PHQ-9 and why should we use it? 
d. Interpretation of PHQ-9 score 
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e. PHQ-9 management and treatment guidelines 
5. Benefits of screening for depression in outpatient cardiology setting   
Increase Depression Screenings. Prior to implementing PHQ-9 screenings to HF 
patients, an office flowchart was developed in collaboration with the quality improvement team. 
This flowchart was used to delegate appropriate staff responsibilities and procedures for 
administering and responding to PHQ-9 scores (Appendix D & E). Also, the office manager and 
information technology (IT) department worked together to formulate a master list of qualified 
patients scheduled between February to the end of March 2019. Inclusion and exclusion criteria 
were provided by the DNP candidate. This master list determined which patients would be given 
the PHQ-9 survey when they presented to the office.  
A daily list of HF patients with patient-labeled PHQ-9 surveys (Appendix B) were 
provided to the front-desk secretaries. Copies of the daily list were also provided to the medical 
assistants to keep track of which patient’s they would need to collect the survey from.  
Each PHQ-9 survey was scanned and uploaded into the patient’s electronic medical 
record for tracking purposes. The original PHQ-9 survey was collected in a drawer located by the 
front-desk secretaries and easily accessible to all staff. 
For a one-month pilot period, the PHQ-9 survey was administered to qualified patients of 
the study. The number of screenings administered and completed was tracked by the DNP 
candidate at weekly intervals. The DNP candidate held bi-weekly meetings with the staff to 
discuss and assess the progress of this initiative. The DNP candidate worked in cooperation with 
the quality improvement team to record and track proper utilization of the PHQ-9 screening tool. 
Data was shared with the medical staff during the final stages of the project.  
Program Evaluation Plan 
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Evaluating Staff Knowledge. Results of the pre- and post-tests were converted into a 
mean score. Scores were compared using a matched pairs t-test to determine if the t-statistic was 
significant (p<.05). Results that identify that the post-test scores were significantly higher than 
pre-test scores would indicate that the educational initiative was effective and there was an 
improvement in knowledge about depression and depression screening in HF patients. 
Evaluating Screening Tool Use. Data collected during the PHQ-9 implementation 
period was used to evaluate if there was an increase in the amount of depression screenings 
administered to qualified patients every week. The number of completed PHQ-9 surveys that 
were collected each week was used to determine if at least 50% of qualified patients were 
screened.   
Weekly comparisons of the PHQ-9 use was shared with the medical staff through 
informal conversations and team meetings to demonstrate project progression.   
Sampling Plan 
Description of Group/Population. The Heart Center’s interdisciplinary team was 
comprised of approximately 17 staff members who provide direct patient care: five physicians, 
one nurse practitioner, one registered nurse, six medical assistants, and four front desk 
secretaries. Staff members were asked to be part of the study and considered a convenience 
sample. The standard of inclusion for medical staff participants included more than three-months 
of work experience at the Heart Center and over the age of 18.  
Patients who were screened for depression using the PHQ-9 survey were also considered 
participants of this project. Patient inclusion criteria included being over the age of 18 and 
having a current heart failure diagnosis established under the problem list tab in their electronic 
medical record. Patient exclusion criteria included the following: unable to read and speak 
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English, history of being diagnosed with depression as evidenced in their electronic medical 
record, screened for depression by another provider with the PHQ-2 or PHQ-9 within the last six 
months, and/or diagnosed with some form of cognitive impairment such as Alzheimer’s disease 
or developmental delay.   
Setting. The project took place in a busy cardiology outpatient practice in Central Oahu. 
The PMMC Heart Center, located on the sixth floor of the physician’s office building, is one out 
of four Heart Centers in Hawai’i that is comprised of expert cardiologists who diagnose and treat 
a full spectrum of heart and vascular conditions for all patients.  
Resources. This project was created to pilot an intervention that would address the 
mental health needs of the community. Partners and executive members of the Hawai’i Pacific 
Health organization recognize the important component that mental wellness plays on mind and 
body health.  
Key stakeholders included the organization, the facility’s outpatient director, office 
manager, providers, medical staff, patients, and the information technology department. The 
DNP candidate met with both the leadership and quality improvement team to discuss 
implementation of depression screening protocols in the cardiology practice.  
Project Timeline  
The proposed project timeline began in May 2018 and culminated in May 2019. After 
completion of the literature search and synthesis outlined in Chapter 1, the next steps of the Iowa 
Model were executed (Titler et al., 2001). Step 5, or piloting the practice change, was completed 
by the end of December 2019. Subsequently, Step 6, or the full practice change implementation, 
began in January 2019. The implementation lasted for one month and concluded in March 2019. 
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Step 7, or the evaluation of the outcomes, took place throughout Spring 2019 and culminated 
with the final project defense in April 2019 (Appendix C). 
 
CHAPTER 3: RESULTS 
Data Analyses Findings 
Staff knowledge. Ten staff members consisting of two males and eight females 
participated in the teaching intervention. The group included two cardiologists, one registered 
nurse, three medical assistants, and four front desk secretaries. All participants were over the age 
of 18 and employed at the Heart Center for over 3 months.  
Changes from pre-test to post-test were assessed using a paired samples t-test which 
showed the results to be significant: t(9) = -2.39, p<.01. The t-value was then converted to a 
correlation to assess strength of effect. Results indicated a large effect size (i.e., >.50) with an r = 
.62 (see Table 3). 
 
Table 3. Pre and Post Test Sample Paired T-Test 
 N Mean mean D Se mean D t p 
Pre-Score 10 5.9 
-2.2 0.919 -2.3941 0.0001 
Post-Score 10 8.1 
 
Depression screening results. Of the 152 patients scheduled during the project pilot 
period, 21 patients rescheduled or cancelled their appointment. Complete data was available for 
only 131 patients. 15 patients were excluded because they did not have a heart failure diagnosis 
seen in their EMR, 4 were excluded due to having a prior diagnosis of depression, 5 were 
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excluded because they were screened for depression using the PHQ-2 or PHQ-9 in the last 6 
months. Ten patients were not given the survey due to staff error, and 10 patients declined to 
complete the survey.  
A total of 87 patients completed the PHQ-9 survey. The sample consisted of 59.8% males 
and 40.2% females (Figure 4). The average age was 69 years and the highest number of patients 
were between 70 to 80 years old (Figure 5). The youngest patient was 40 years old, while the 
oldest patient was 96 years old. Majority of the scheduled visits were follow-up appointments 
(Figure 6). Table 4 displays a list of ICD-10 codes and the HF diagnosis. The most common 
ICD-10 code or HF diagnosis was I50.9 or unspecified HF. The least common ICD-10 code or 










Figure 5. Frequency by Age (n=87)   
 
 








Figure 8. Frequency by HF Diagnosis  
 
 
Table 4. ICD-10 Code and Heart Failure Type 
 
ICD-10 Code Heart Failure Type 
I50.20 Systolic 
I50.21 Acute systolic 
I50.22 Chronic systolic 
I50.23 Acute on chronic systolic 
I50.30 Diastolic 
I50.31 Acute diastolic heart failure 
I50.32 Chronic diastolic 
I50.33 Acute on chronic diastolic 
I50.40 Combined systolic and diastolic 
I50.41 Acute combined systolic and diastolic 
I50.42 Chronic combined systolic and diastolic 
I50.9 Heart failure, unspecified 
  
 
Based on the 87 completed PHQ-9 surveys, the average PHQ-9 score was 2.94. The 
lowest score was 0 and the highest score was 19. In terms of depression severity, 61.7% of 
patients scored 0 to 4 (none or minimal depression), 9.3% of patients scored 5 to 10 (mild 
depression), 9.3% of patients scored 10 to 14 (mild/moderate depression), less than 1% of 
patients scored 15 to 20 (mod/severe depression), and 0% of patients scored more than 20 
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(severe depression). Of the 12 patients who indicated a PHQ-9 score of 10 or more, 2 patients 
were referred for further psychological evaluation. One patient declined referral.  
Interpretation of Results 
 A low prevalence of depression found in this study. Less than 20% of total participants 
(or 21 patients) indicated mild, moderate, or moderate-severe depression. 13.8% had a PHQ-9 
score equal to or greater than 10. Approximately 60% of participants indicated no/minimal 
depression. Of the 107 we attempted to screen, 18.7% of patients did not complete the PHQ-9 
survey due to staff error or because the patient declined.  
 






Figure 10. Percentage by Depression Severity (n=107) 
 
 
At the project’s end, more than 50% of HF patients scheduled during the project pilot 
period were screened for depression. For patients who scored equal to or greater than 10, the 
provider attempted to validate the patient’s score by inquiring about his/her feelings and the 
degree of impact that depression had on their day-to-day activities. By the end of the pilot period, 
a total of  2 patients were referred to the Psychologist. One patient denied referral.   
The project data supports the achievement of overall goals and objectives of this practice 
intervention. By the project’s end, there was an improvement in staff knowledge about 
depression and depression screening in HF patients. More importantly, there was an increase in 
number of HF patients who were screened for depression.  
 
CHAPTER 4: DISCUSSION 
Barriers and Limitations  
Limitations of this study include relatively small sample size, the use of a convenience 
sample, and inclusion of only English-speaking patients. Our sample consisted of more men than 
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women so this may underestimate the impact of depression. Studies show depression is prevalent 
in men and low educational levels (Son et al., 2012).  
This quality improvement project provides an assessment of depression in HF patients 
however, conclusions from our data may not reflect the true prevalence of clinical depression.  
Detecting mild depressive disorders are challenging because patients may not feel comfortable 
sharing these psychosocial concerns due to the negative stigma and attitudes associated with 
depression. Depressed patients might have been less willing than non-depressed patients to 
participate in this study, resulting in an underestimate of the prevalence of clinical depression.  
Time constraints attributable to short patient visit times and busy provider schedules were 
another limitation to the study as 18% of attempted screenings were incomplete at the project’s 
end.   
 
Conclusion 
In conclusion, developing a process for depression screening and management is an 
important aspect of care when managing patients with chronic diseases such as heart failure. 
Thoughts and emotions are a physical, chemical-embodied manifestation that affects the body as 
a whole. Modern medicine tends to divide the body into parts however, attention to how the 
mind and body are interconnected can allow healing to start. This evidence-based research 
project has brought some insight to the role of depression in patients with HF. Future research 
should include NYHA classes as disease severity is linked to depression prevalence. 
Subsequent efforts should also be made to evaluate the inpatient HF population for depression, 
as there may be more substantial prevalence and severity of depression. More importantly, health 
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policies should include establishing appropriate behavioral health resources and interventions 
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